SCHEMBL788701

SCHEMBL788701

c1ccc(-c2ccccc2-c2ccc3sc4c(-c5ccc6[nH]c7ccc(-c8cc(-c9ccccc9-c9ccccc9)cc9c8sc8ccc(-c%10ccccc%10-c%10ccccc%10)cc89)cc7c6c5)cc(-c5ccccc5-c5ccccc5)cc4c3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 2/20 0.39
TNKS2 Q9H2K2 2/20 0.39
ALOX5 P09917 1/20 0.39
LIMK1 P53667 1/20 0.36
PIM3 Q86V86 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36
PIM1 P11309 3/20 0.35
PIM2 Q9P1W9 3/20 0.35
RXFP1 Q9HBX9 1/20 0.35
CDK4 P11802 2/20 0.35
CCND1 P24385 2/20 0.35
WEE1 P30291 3/20 0.34
CHEK1 O14757 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10227354 0.96 TNKS (0.39) TNKSTNKS2ALOX5LIMK1PIM3
SCHEMBL786979 0.90 LIMK1 (0.43) TNKSTNKS2ALOX5LIMK1PIM3
SCHEMBL788550 0.90 LIMK1 (0.43) TNKSTNKS2ALOX5LIMK1PIM3
SCHEMBL786981 0.88 LIMK1 (0.41) TNKSTNKS2ALOX5LIMK1PIM3
SCHEMBL10227377 0.86 LIMK1 (0.40) TNKSTNKS2ALOX5LIMK1PIM3
SCHEMBL10227353 0.86 LIMK1 (0.40) TNKSTNKS2ALOX5LIMK1PIM3
SCHEMBL788260 0.85 CDK4 (0.40) TNKSTNKS2LIMK1PIM3MEN1
SCHEMBL788651 0.85 ALOX5 (0.42) TNKSTNKS2ALOX5MEN1KMT2A
SCHEMBL10227355 0.84 LIMK1 (0.39) TNKSTNKS2ALOX5LIMK1PIM3
SCHEMBL10225928 0.83 ALOX5 (0.58) TNKSTNKS2ALOX5LIMK1PIM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9450188-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2016-09-20 US disclosed
US-20140145175-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-05-29 US disclosed
US-8642782-B2 Carbazole derivative, light-emitting element material and organic semiconductor material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2014-02-04 US disclosed
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071668-A1 Carbazole Derivative, Light-Emitting Element Material and Organic Semiconductor Material SLC39A3, SULT1A1, NUTF2 TNKS 4076/4885TNKS2 3776/4885ALOX5 1162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.